Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/13/2017 02/14/2017 02/15/2017 02/16/2017 02/17/2017 Date
2.36(c) 2.42(c) 2.4(c) 2.28(c) 2.28(c) Last
2 274 273 4 256 583 1 293 706 1 408 219 1 769 431 Volume
+8.26% +2.54% -0.83% -5.00% 0.00% Change
More quotes
Financials ($)
Sales 2016 4,21 M
EBIT 2016 -30,9 M
Net income 2016 -29,6 M
Debt 2016 -
Yield 2016 -
Sales 2017 25,9 M
EBIT 2017 -19,7 M
Net income 2017 -38,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 86,2x
Capi. / Sales2017 14,0x
Capitalization 363 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
02/10 GERON CORP : Change in Directors or Principal Officers (form 8-K)
01/09 GERON CORP : Results of Operations and Financial Condition, Regulation FD Disclo..
2016 Geron Reports Imetelstat Presentations at American Society of Hematology Annu..
2016 GERON : Biotech Stocks Under Scanner -- Geron, Keryx Biopharma, Heat Biologics, ..
2016 GERON CORP : Other Events (form 8-K)
2016 Geron Announces November Investor Conference Presentation Webcasts
2016 ASH 2016 : Janssen to Present 43 Abstracts with Data on Ibrutinib, Daratumumab a..
2016 GERON : reports 3Q loss
2016 GERON CORP : Results of Operations and Financial Condition, Financial Statements..
2016 GERON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
More news
Sector news : Bio Therapeutic Drugs
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
02/13 TEVA PHARMACEUTICAL INDUSTRIES : seeks CEO with pharma background to lead recove..
02/09DJAppeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug
02/08 Weak pound buoys GSK but drugmaker warns on 2017 generic threat
More sector news : Bio Therapeutic Drugs
Latest Tweets
02/14$GERN long setup.. big gap above 
02/075/And, Vir Bio, Geron, Clarus Ventures, Denali $FPRX and Nuvelution Pharma --..
1
02/06Want the latest upgrades & downgrades for $LPNT $DTEGY $GERN $TRVG $SMP? .. 
02/05$GERN "BlackRock Inc. just increased their shares in GERN" on ADFN InvestorsH.. 
01/1122 Stocks Moving In Wednesday's PreMarket  
More tweets
Qtime:19
News from SeekingAlpha
01/03 NICK'S PICKS : Beating The S&P 500 Soundly In 2016
2016 After Hours Gainers / Losers
2016 BACKTESTING 101, PART 4 : Frictional Costs, To Hedge Or Not To Hedge, And Benchm..
2016 Should Geron Opt-In?
2016 What Are The Actionable Takeaways From Geron's ASH Presentations?
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 4,38 $
Spread / Average Target 92%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Ho Young Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION10.14%363
AMGEN, INC.18.52%127 620
CELGENE CORPORATION4.67%94 258
GILEAD SCIENCES, INC.-2.46%92 024
REGENERON PHARMACEUTIC..1.11%39 375
ACTELION LTD21.09%28 677
More Results